Alex Speiser @alex_speiser

Entrepreneur. CEO, Co-founder at 2A Biosciences Los Angeles Joined September 2014

Tweets

76
Followers

267
Following

366
Likes

1K

Joshua Baer ⚙️ @JoshuaBaer

3 months ago

🧬 #2ABiosciences is developing serotonin-based drugs that treat neurodegeneration without the hallucinogenic effects of psychedelics. Their small molecules target 2A receptors to drive regeneration, reduce inflammation, and protect brain and eye health at the source. THIS WAS…

1 1 1 135 0

Alex Speiser @alex_speiser

3 months ago

Oh boy

0 0 2 155 0

Download Image

Diego Saez Gil @dsaezgil

a year ago

Someone should make a bootcamp to help turn young climate activist into climate entrepreneurs. Their fiery passion, creativity and courage can be so much more impactful channeled towards building the solutions the planet needs! Who’s making this?

35 10 136 15K 22

Bruce Booth @LifeSciVC

a year ago

With the approval of tovorafenib by $DAWN, it’s worth celebrating the long journey of R&D in our business. Others have written on this better (@JacobPlieth @SFBIZronleuty), but here’s the short story: The molecule was discovered in a collaboration between Sunesis & Biogen that…

4 15 129 19K 21

Download Image

Nick Field @nick_field90

4 years ago

@mattyglesias Pictured: The only two Presidents to deliver us Dune film adaptations

18 161 1K 0 24

Download Image

Peter Kolchinsky @PeterKolchinsky

2 years ago

The RA Capital team is kicking off 2024 with another detailed Semper Maior (always better) breakdown of the sector performance, what drove returns in 2023, predictions for 2024, and commentary we think most should find relevant. Over 20 figures/charts loaded with data. Keyword…

10 18 130 44K 96

Paras Sharma @paras_biotech

2 years ago

Cowen's top 10 potential surprises of 2024 $XBI

12 38 214 89K 117

Download Image

Charles Nichols @lab_nichols

2 years ago

5-HT2A receptor in cellular membrane. looking forward to testing different psychedelics to tease out how anti inflammatory ones affect receptor structure differently than non anti inflammatory ones. A big shoutout to @zenbrainest for depositing the active state structures!!!

11 20 136 12K 8

Download Video

Greg Kubin @kubeans

2 years ago

why ketamine and psilocybin centers have struggled lately: 1) capital markets - many of these companies raised money during peak hype. interest rates were near zero. today, a company's next round of financing has become much harder to secure. 2) the ketamine therapy market is…

7 5 33 10K 12

Robert Nelsen @rtnarch

3 years ago

Amazing moment in fusion science at LLNL. Long way to go from here, but hopeful. Helion also a very interesting approach. A great illustration of how Science will solve our climate problems, not restricting commerce.